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In many cases, neurons acquire distinct identities
as their axons navigate toward target cells and
encounter target-derived signaling molecules. These
molecules generate retrograde signals that activate
subtype-specific gene transcription. Mechanisms
by which axons convert the complex milieu of sig-
naling molecules into retrograde signals are not fully
understood. Here, we examine retrograde signaling
mechanisms that specify neuronal identity in the
trigeminal ganglia, which relays sensory information
from the face to the brain. We find that neuron spec-
ification requires the sequential action of two target-
derived factors, BDNF and BMP4. BDNF induces the
translation of axonally localized SMAD1/5/8 tran-
scripts. Axon-derived SMAD1/5/8 is translocated to
the cell body, where it is phosphorylated to a tran-
scriptionally active form by BMP4-induced signaling
endosomes and mediates the transcriptional effects
of target-derived BDNF and BMP4. Thus, local trans-
lation functions as a mechanism by which coincident
signals are converted into a retrograde signal that
elicits a specific transcriptional response.
INTRODUCTION
The nervous system is characterized by precise connectivity
between neurons and specific target cells. A mechanism to
ensure that neurons are matched to appropriate targets is by
the differentiation of neurons into specific subtypes after their
axons encounter inductive cues expressed in target fields
during nervous system development (Hippenmeyer et al.,
2004). The target-derived signaling molecules trigger the forma-
tion of incompletely understood signals that are propagated
along the axon to the neuronal cell body. This form of retrograde
signaling has been linked to changes in gene expression that
lead to neuronal differentiation (Hippenmeyer et al., 2004;
Nishi, 2003).
The embryonic trigeminal ganglion is a readily accessible
system in which the interaction of target-derived factors and
neuronal patterning has been explored (Davies, 1988). Thetrigeminal ganglion conveys sensory information from the face
to somatosensory centers in the central nervous system. The
trigeminal ganglion has three main peripheral axonal branches,
the ophthalmic, maxillary, and mandibular, which innervate the
corresponding regions of the face. Sensory information is then
conveyed from the ganglia to the brainstem nuclei via a centrally
projecting axonal bundle. The neurons that innervate each of
these regions in the face are spatially segregated into specific
domains within the ganglia and exhibit distinct gene expression
profiles, reflecting the division of these otherwise similar trigem-
inal neurons into distinct subtypes (Hodge et al., 2007). Some of
these differentially expressed genes affect axonal pathfinding
programs that allow the central projections of these neurons to
innervate the brainstem (Hodge et al., 2007).
Studies on the mechanism of the acquisition of these distinct
identities have focused on BMP4, a TGF-b family member ex-
pressed in the distal epithelium of the maxillary and ophthalmic
regions in the face (Hodge et al., 2007). As axons grow into these
regions, they encounter BMP4, which results in a retrograde
signal that leads to nuclear accumulation of the phosphorylated
and transcriptionally active forms of the SMAD1, 5, and 8 tran-
scription factors (Nohe et al., 2004). Additionally, Tbx3, a pre-
dicted SMAD1 target (Chen et al., 2008), is also selectively
induced in the ophthalmic- and maxillary-innervating neurons
in a BMP4-dependent manner (Hodge et al., 2007). This retro-
grade signaling contributes to the gene expression differences
between the ophthalmic- and maxillary-innervating neurons
and mandibular-innervating trigeminal neurons (Hodge et al.,
2007). However, the nature of the retrograde BMP4 signal, and
whether other factors are also involved in patterning the trigem-
inal ganglia remain unknown.RESULTS
ASignaling EndosomeMechanismMediates Retrograde
BMP4 Signaling
We first sought to recapitulate retrograde BMP4 signaling in vitro
by culturing dissociated E13.5 rat trigeminal ganglia neurons in
microfluidic chambers (Taylor et al., 2005). In these devices,
axons grow through a 450 mm microgroove barrier and appear
in the axonal compartment by 2 days in vitro (DIV). Because
the axons are fluidically isolated from the cell bodies, this
approach allows experimental treatments to be applied selec-
tively to axons (Taylor et al., 2005; Figure S1A, available online).Neuron 74, 95–107, April 12, 2012 ª2012 Elsevier Inc. 95
Figure 1. A Signaling EndosomeMechanismMedi-
ates Retrograde BMP4 Signaling
(A) Axonal application of BMP4 induces increases in
nuclear pSMAD1/5/8 and Tbx3 levels. Dissociated E13.5
trigeminal ganglia neurons were cultured in microfluidic
chambers for 2 DIV, to allow axons to cross to the axonal
compartment. Application of BMP4 (20 ng/ml) to the
axonal compartment leads to an increase in pSMAD1/5/8
and Tbx3 levels in the nuclei of trigeminal neurons. Shown
are anti-pSMAD1/5/8 and anti-Tbx3 immunostaining of
neurons following axonal application of BMP4 for 1 hr
(pSMAD1/5/8) and 4 hr (Tbx3), respectively.
(B and C) The BMP4 retrograde signal is conveyed by
molecular motors and requires BMP4 receptor activity in
the cell body. BMP4 treatment in axons induced a 2.2-fold
increase in pSMAD1/5/8 (B) and a 2.0-fold increase in
Tbx3 (C) immunofluorescence intensity in cell bodies. This
effect was blocked by coapplication of the retrograde
motor inhibitor EHNA (1 mM) to the axons. Retrograde
BMP4 signaling was also blocked by application of
the BMP receptor inhibitor dorsomorphin (DMP, 10 mM) to
the cell-body compartment, but not by application of the
inhibitor to the axonal compartment.
(D) Overexpression of dynamitin impairs BMP4 retrograde
signaling. Axonal BMP4 treatment induced a 2.5-fold
increase of pSMAD (red, arrows) only in the nuclei of
neurons not expressing dynamitin (arrows). However, the
increase in pSMAD was not seen in neurons over-
expressing dynamitin (indicated by nGFP expression,
green, arrowheads). The graph shows the quantification.
(E) Retrograde trafficking of biotinylated BMP4 from axons
to the soma. Application of biotinylated BMP4 (20 ng/ml)
to axons for 1 hr resulted in prominent anti-biotin immu-
nofluorescence signals in the cell body (red). As controls,
application of biotinylated BSA (20 ng/ml) or vehicle (PBS/
borate/glycine) resulted in only baseline labeling in cell
bodies.
For quantification, all data are mean ± SEM, n = 3
replicates. Between 100 and 200 cells were analyzed for
each condition in each experiment. ns, not significant,
**p < 0.01, *p < 0.05, compared with axonal BMP4 treat-
ment group as indicated (B and C) or vehicle treatment
group (D), post hoc Tukey test after one-way ANOVA.
Scale bars represent 20 mm (A); 10 mm (D and E). See also
Figure S1.
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Local Translation Regulates Trigeminal PatterningThe majority of the neurons that are adjacent to the micro-
grooves send an axon to the axonal compartment, as detected
by retrograde labeling of cell bodies by axonal application of
CM-DiI (Figure S1A).
Selective application of BMP4 to the axonal compartment
resulted in an increase in nuclear pSMAD1/5/8 (Figures 1A, 1B,
S1B, and S1C). pSMAD1/5/8 levels nearly doubled within
15 min, with further increases over 1–2 hr (Figure S1D). Total
SMAD1/5/8 localization and levels were unaffected (Figures
S1E and S1F), indicating that BMP4 increases the fraction of
SMAD1/5/8 that is phosphorylated.
Retrograde BMP4 signaling also increased Tbx3 expression at
4 hr (Figures 1A, 1C, S1B, and S1G), with further increases over
a 24 hr period (data not shown). This delay in the appearance
of Tbx3 is consistent with a requirement for Tbx3 transcription
and translation following retrograde BMP4 signaling. Similar96 Neuron 74, 95–107, April 12, 2012 ª2012 Elsevier Inc.increases in pSMAD and Tbx3 levels in the soma following
axonal BMP4 treatment were also observed using western
blotting (Figures S1H and S1I). Notably, the retrograde signal
generated by axonal application of BMP4 is as robust as
BMP4 signals generated by activation of BMP4 receptors in
the cell body, based on their similar ability to elevate pSMAD
and Tbx3 levels (Figures S1J and S1K).
We next asked if the retrograde signal is conveyed to the cell
body by molecular motors. Application of the dynein inhibitor
erythro-9-[3-(2-hydroxynonyl)] adenine (EHNA) (Penningroth,
1986) to the axonal compartment blocked the appearance of
pSMAD1/5/8 and Tbx3 induced by axonal application of BMP4
(Figures 1B and 1C). Furthermore, expression of dynamitin,
which disassembles the dynactin complex required for dynein
motor transport (Burkhardt et al., 1997), similarly blocked the
increase in nuclear pSMAD by BMP4 treatments in axons
Figure 2. Retrograde BMP4 Signaling Requires
Intra-axonal Protein Synthesis
(A and B) Retrograde BMP4 signaling requires intra-axonal
protein synthesis. The increase in nuclear pSMAD1/5/8 (A)
and Tbx3 (B) induced by axonal BMP4 application were
inhibited by inclusion of protein synthesis inhibitors ani-
somycin (Aniso, 200 mM) or cycloheximide (CHX, 10 mM) in
the axonal compartment. Protein synthesis inhibitors
and BMP4 were added to the axonal compartment at the
same time.
(C–E) Repression of OC1, OC2, and Hmx1 by retrograde
BMP4 signaling requires intra-axonal protein synthesis.
Application of BMP4 to the axonal compartment for 4 hr
leads to a decrease in OC1 (C), OC2 (D), and Hmx1 (E)
levels in the cell body by 44.3% (OC1), 60.0% (OC2), and
29.4% (Hmx1), respectively. The decrease in OC1, OC2,
and Hmx1 levels in the cell body were inhibited by inclu-
sion of protein synthesis inhibitor anisomycin (Aniso) in the
axonal compartment.
For quantification, all data are mean ± SEM, n = 3 repli-
cates. Between 100 and 200 cells were analyzed for each
condition in each experiment. **p < 0.01, *p < 0.05, com-
pared with axonal BMP4 treatment group as indicated,
post hoc Tukey test after one-way ANOVA. See also
Figure S2.
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Local Translation Regulates Trigeminal Patterning(Figure 1D). Together, these data suggest that signaling mole-
cules conveyed from distal axons in a dynein-dependent manner
mediate axonal BMP4 signaling.
In the case of the neurotrophins, retrograde signaling has been
shown to be mediated by ‘‘signaling endosomes’’ containing en-
docytosed receptors that are translocated in an active ligand-
bound form to the cell body where they activate their effectors
(Cosker et al., 2008; Iba´n˜ez, 2007). To test whether a similar
mechanism may be involved in retrograde BMP4 signaling, we
first asked whether the activity of BMP receptors is required in
the cell body after axonal application of BMP4. Dorsomorphin,
DMH2, and LDN193189, selective and reversible inhibitors of
BMP type I receptors ALK2, ALK3, and ALK6, block BMP
signaling, but not signaling by related TGF-b family members
(Yu et al., 2008). Application of these inhibitors to the cell body
blocked the increase in pSMAD1/5/8 and Tbx3 that was induced
by application of BMP4 to axons (Figures 1B, 1C, and S1L–S1N).
These data suggest that retrograde BMP4 signaling results in the
appearance of active BMP4 receptors in the cell body, which is
required for retrograde BMP4 signaling.
In these experiments, we confirmed that cell body levels of
SMAD1/5/8 were unchanged (Figure S1F) and no signs of cyto-
toxicity were observed during the time course of the experi-
mental treatments (Figure S1O). Local action of the inhibitor in
the microfluidic chambers was also confirmed (Figure S1P).
To further test the idea that retrograde BMP4 signaling
involves axonally derived activated BMP4 receptors, we moni-
tored the translocation of BMP4 from the axon to the soma.
Application of biotinylated BMP4 to the axonal compartment
resulted in the appearance of biotin signals throughout the cell
body, while biotinylated BSA failed to be retrogradely trafficked
(Figure 1E). Taken together, these data support a model in which
axonal application of BMP4 elicits a retrograde signal that is
translocated by dynein, and involves the appearance of both
BMP4 and active BMP4 receptors in the cell body.Requirement of Intra-axonal mRNA Translation
in Retrograde BMP4 Signaling
During the development of the nervous system, intra-axonal
mRNA translation is a component of several signaling pathways,
notably those involving axon guidance cues (Lin and Holt, 2008;
Martin and Ephrussi, 2009). We therefore asked if local protein
synthesis is required for retrograde BMP4 signaling. Coapplica-
tion of either of the translation inhibitors cycloheximide or aniso-
mycin with BMP4 to axons substantially blocked retrograde
BMP4 signaling (Figures 2A and 2B). The effect of axonal aniso-
mycin treatment is not due to inhibition of protein synthesis in
the cell body, as a labile control protein ODC in cell bodies is
not affected (Figure S2A). In addition to inducing Tbx3, retro-
grade BMP4 signaling also leads to the repression of OC1,
OC2, and Hmx1 in the cell body (Hodge et al., 2007). These
effects were also blocked by axonal application of translation
inhibitors (Figures 2C–2E).
We considered the possibility that inhibition of local translation
could impair the retrograde translocation of BMP4 signaling
endosomes. However, application of anisomycin to axons did
not prevent the retrograde transport of biotinylated BMP4 (Fig-
ure S2B). Under these experimental conditions, the translation
inhibitors did not elicit axonal or cell body toxicity compared to
vehicle treatment (Figures S2C and S2D). Additionally, the
effects of the protein synthesis inhibitors were not due to alter-
ations in the levels of axonal BMPR1a, 1b, and 2 or cell body
SMAD1/5/8, or due to diffusion of the inhibitors into the cell
body compartment (Figures S2E–S2J, S1F, and S2K). These
data indicate that translation of axonal mRNA(s) are required
for retrograde BMP4 signaling.
SMAD 1, 5, and 8 mRNA and Protein Are Localized
to Trigeminal Axons
To identify axonal mRNAs that may mediate retrograde BMP4
signaling, we considered proteins that are present in axonsNeuron 74, 95–107, April 12, 2012 ª2012 Elsevier Inc. 97
Figure 3. SMAD Protein and mRNA Are
Localized to Axons of Trigeminal Ganglia
Neurons
(A) SMAD1/5/8 immunohistochemistry (red)
reveals high levels in themaxillary (MX) projections
(arrows) of trigeminal ganglia (TG), but not in the
mandibular (MD) projections (outlined by white
dotted line, arrowhead). Axon bundles were visu-
alized by Tau1 immunofluorescence (green).
(B) Expression of SMAD1, 5, and 8 in cell bodies
and axons of trigeminal ganglia (TG) neurons.
Immunohistochemistry of E13.5 rat embryo
sagittal sections using specific antibodies against
individual SMAD1, 5, and 8 isoforms shows SMAD
protein in trigeminal ganglia cell bodies (upper
panels). Each SMAD isoform was also detected in
the maxillary axon bundles (lower panels, arrows).
DAPI signal is excluded from axon bundles.
(C)SMAD1, 5, and 8 transcripts are detected in the
distal axons of trigeminal neurons. SMAD1, 5, and
8 mRNA were detected by RT-PCR using RNA
harvested from the distal axon and neuronal soma,
respectively. BMPR1a, BMPR1b, BMPR2, and
Tbx3 transcripts were not detected in axons.
b-actin is the positive control for axonal localiza-
tion, and g-actinwas used as a negative control to
exclude the possibility of contamination of the
axonal fraction with cell body-derived material. All
transcripts were detected in the trigeminal cell
bodies.
(D) Localization of SMAD1, 5, and 8 transcripts to
axons by fluorescence in situ hybridization (FISH).
Dissociated E13.5 rat trigeminal ganglia neurons
were cultured for 2 DIV. SMAD1, 5, 8, and b-actin
transcripts were detected in trigeminal axons in a characteristic punctate localization (red) typically seen with axonal transcripts (Lin and Holt, 2008). The control
transcript, g-actin, as well as Tbx3, exhibited similar minimal reactivity as observed with a sense SMAD1 probe. GAP43 immunostaining (green) was used to
visualize axonal borders. Insets, FISH labeling in the cell bodies of trigeminal neurons. The graph shows the quantification.
Bars indicatemean ± SEM, n = 3 replicates. Aminimumof 15 axons for each probewas analyzed. ns, not significant, *p < 0.05 (comparedwith sense probe group,
post hoc Tukey’s test after one-way ANOVA). Scale bars represent 100 mm (A and B); 10 mm (D). See also Figure S3.
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Local Translation Regulates Trigeminal Patterningand may be translated locally. Although transcription factors are
typically localized in the nucleus, previous studies have detected
prominent labeling of phospho-SMAD1/5/8 (pSMAD1/5/8) in
certain axonal branches of the trigeminal ganglia (Hodge et al.,
2007). The axonal localization of these transcription factors rai-
ses the possibility that they are synthesized locally and that
this axonal pool of SMAD1/5/8 has a role in conveying retrograde
patterning signals from target tissues.
Although pSMAD1/5/8 is selectively localized to ophthalmic
and maxillary axons (Hodge et al., 2007), the absence of
pSMAD1/5/8 immunoreactivity inmandibular axons could reflect
the absence of SMAD phosphorylation in these axons, or the
absence of SMAD protein altogether. Immunostaining using an
anti-SMAD1/5/8 antibody shows labeling in the ophthalmic and
maxillary axons, but not the mandibular axons (Figures 3A and
S3A; data not shown), indicating that SMAD1/5/8 protein is
absent from these axons.
To determine which isoform(s) are localized to trigeminal
ganglia axons, we stained E13.5 rat trigeminal ganglia histolog-
ical sections using isoform-specific antibodies. SMAD1, 5, and
8 labeling were found in both neuronal cell bodies and axons
of the trigeminal ganglia (Figure 3B). Higher magnification
images showed that SMAD1, 5 and 8 staining is specific, with98 Neuron 74, 95–107, April 12, 2012 ª2012 Elsevier Inc.labeling limited to neuronal cells colabeled with the neuronal
marker Isl1, but not in the surrounding non-neuronal cells
(Figure S3B).
We next asked if SMAD1, 5, or 8 transcripts are localized to
trigeminal axons. As a first approach, we used RT-PCR of axonal
mRNA. We prepared highly pure axonal preparations from
trigeminal ganglia cultures using microfluidic chambers (Fig-
ure S3C). g-actin, which has previously been shown to be
excluded from axons (Bassell et al., 1998), was detected in cell
body fractions, but not the axonal fraction by RT-PCR (Fig-
ure 3C). However, RT-PCR indicated that, b-actin, a well-charac-
terized axonal mRNA (Olink-Coux and Hollenbeck, 1996), as well
as SMAD1, 5, and 8 mRNAs, were found in axons (Figure 3C).
Because SMAD1/5/8 protein is localized in maxillary and
ophthalmic axons, but not mandibular axons, we asked if
SMAD1/5/8 mRNA is also selectively localized to maxillary and
ophthalmic axons. Despite the selective localization of
SMAD1/5/8 protein, SMAD1, 5, and 8 transcripts were found in
axons of both maxillary/ophthalmic and mandibular subpopula-
tions (Figure S3D), indicating that the difference in SMAD1/5/8
expression is not due to differences in RNA localization.
As a second approach, we examined the localization of SMAD
isoform transcripts by fluorescence in situ hybridization (FISH).
Figure 4. SMAD1/5/8 Is Locally Synthesized
in Axons
(A) Axonal levels of SMAD1/5/8 are dependent on
axonal protein synthesis. Application of anisomy-
cin (Aniso, 200 mM) to the axonal compartment for
4 hr resulted in a 62.8% reduction of axonal
SMAD1/5/8 (red) protein levels. SMAD1/5/8 fluo-
rescence intensity was normalized to the area
defined by Tau1 fluorescence in the distal 50 mmof
the axon, including the growth cone.
(B) FRAP (fluorescence recovery after photo-
bleaching) analysis of Dendra2-SMAD1 in axons.
pDendra2-SMAD1-30UTRSMAD1 was transfected
into E13.5 trigeminal neurons and axons were
severed from the cell body after 2 DIV. Expression
of the fusion protein in axons was detected by its
green fluorescence. Photobleaching was carried
out in the distal axon (>500 mm from soma), which
resulted in a near complete elimination of green
signals. The recovery of green Dendra2-SMAD1
signal after photobeaching was monitored by live-
cell imaging. A gradual appearance of green signal
was observed, which increased 3.2-fold by
30 min. This recovery was blocked by treatment
with anisomycin. The graph shows the quantifi-
cation of green signal recovery.
For quantifications, bars indicate mean ± SEM, n = 3 replicates. More than 20 axons for each treatment were analyzed. ns, not significant; *p < 0.05 (unpaired,
two-tailed t test; A); **p < 0.01 (post hoc Tukey’s test after one-way ANOVA as indicated; B). Scale bars represent 10 mm. See also Figure S4.
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Local Translation Regulates Trigeminal PatterningRiboprobes directed against either SMAD1, 5, or 8, as well as
b-actin, exhibited punctate localization along the axon and in
the growth cone of E13.5 DIV2 trigeminal neurons, while g-actin
and Tbx3 mRNA, were not detected in axons (Figure 3D).
Axonal mRNAs have rarely been detected in tissue sections by
in situ hybridization due to minimal axoplasmic volume, low
levels of axonal mRNA, and the punctate and intermittent local-
ization of axonal transcripts (Lin and Holt, 2008; Martin and
Ephrussi, 2009). However, we detected clear and specific
signals for each SMAD transcript along trigeminal axons in
E12.5 mouse embryos (Figure S3E). The ability to detect
SMAD transcripts in axons in tissue sections suggests that these
mRNAs may be relatively abundant in trigeminal axons.
Together, these data indicate that transcripts encoding
SMAD1, 5, and 8 are found in the axons of trigeminal neurons.
Local Synthesis Contributes to Axonal SMAD1/5/8
Levels
We next sought to determine whether local translation contrib-
utes to SMAD levels in axons. As a first approach, we examined
intra-axonal SMAD synthesis in E13.5 trigeminal neurons
cultured in microfluidic chambers for 2 days. SMAD1/5/8 levels
were measured by quantitative immunofluorescence, with back-
ground levels measured in SMAD1/5/8 knockdown neurons
(Figures S4A–S4D). Application of anisomycin to the axonal
compartment for 4 hr resulted in a 62.8% decrease in total
axonal SMAD1/5/8 levels, compared to treatment with vehicle
(Figures 4A, S4E, and S4F). Together, these data indicate that
maintenance of SMAD1/5/8 levels requires intra-axonal protein
synthesis.
As a second strategy to examine the source of axonal SMAD1/
5/8, we performed FRAP (fluorescence recovery after photo-bleaching) analysis using a photoconvertible reporter of
SMAD1 translation. Trigeminal neurons were transfected with a
construct comprising the photoconvertible protein Dendra2
(Chudakov et al., 2007) fused to SMAD1, including its 30UTR.
The axons were severed after 2 days. By examining only severed
axons, any possible contribution to axonal SMAD levels by
anterograde SMAD transport from the cell body is eliminated.
Dendra2-SMAD1-30UTRSMAD1 was photobleached in distal
axons. Following photobleaching, recovery of green fluorescent
Dendra2-SMAD1 was detected within 10 min, with continued
increases over 30 min (Figure 4B). This effect was completely
blocked by treatment with anisomycin, indicating that local
synthesis of SMAD1 accounts for the increase in Dendra2-
SMAD1 in distal axons.
We next asked if anterograde transport from cell bodies
substantially contributes to the levels of SMAD proteins in axons.
Dendra2 or Dendra2-SMAD1 was expressed and photocon-
verted to the red fluorescent form in the cell body. The increase
in red signals in distal axons was monitored over 60 min. Red
fluorescent Dendra2-SMAD1 protein could not be detected in
distal axons, while Dendra2 was readily detected (Figure S4G).
These data further support that the idea that axonal SMAD is
derived primarily from local synthesis and not from transport
from the cell body.
These experiments, as well as an additional approach using
axon-specific knockdown of SMAD1, 5, and 8 mRNA (see Fig-
ure 6A, below), indicate that SMAD1/5/8 levels in axons are
mainly dependent on local synthesis.
Axonal SMAD1/5/8 Traffics from Axons to Cell Bodies
The rapid decline in axonal SMAD1/5/8 levels following protein
synthesis inhibition suggests that SMAD1/5/8 is rapidly turnedNeuron 74, 95–107, April 12, 2012 ª2012 Elsevier Inc. 99
Figure 5. SMAD1/5/8 Retrogradely Traffics
from Axon to Soma
(A) Time-dependent depletion of SMAD1/5/8 from
axons is mediated by molecular motors. E13.5 rat
trigeminal explants were cultured and axons were
severed from the cell body after 2 DIV. A 55.4%
loss of SMAD1/5/8 immunofluorescence intensity
in the severed axons was observed after 1 hr
treatment of anisomycin compared with vehicle.
EHNA, but not LLnL, blocked the reduction of
axonal SMAD1/5/8 levels. All experimental
conditions included BMP4. Scale bar represents
10 mm.
(B) Locally synthesized SMAD1/5/8 protein is
retrogradely trafficked back to cell body. L-azi-
dohomoalanine (AHA) was added to the axonal
compartment to label the axonally synthesized
proteins. Axons were treated with anisomycin or
BMP4, as indicated. Lysates were collected from
cell body compartments and immunoprecipitation
with anti-pSMAD1/5/8 antibody was carried out,
followed by Click-iT reaction to biotinylate AHA-
labeled proteins. Anti-biotin western blotting
detected AHA-labeled pSMAD1/5/8 in the cell
body compartment. Levels of axonally derived
pSMAD1/5/8 were increased upon axonal appli-
cation of BMP4, while reduced levels were de-
tected upon axonal application of anisomycin. The
quantification is shown on the right.
(C) Photoconversion of Dendra2-SMAD1 in axons.
pDendra2-SMAD1-30UTRSMAD1 was transfected
into E13.5 trigeminal neurons. Expression of the
fusion protein was detected by its green fluores-
cence. After photoconversion of a 1 mm segment
(>500 mm from soma) in the axon by 0.1 s irradia-
tion with a 406 nm laser, the photoconverted
signal was detected (red). Scale bar represents
10 mm.
(D) Translocation of Dendra2-SMAD1 protein from
the axon to the nucleus. pDendra2-SMAD1-
30UTRSMAD1 and pDendra2 expression constructs
were transfected into E13.5 trigeminal neurons,
respectively. After photoconverting 20 1 mm
segments (>50 mm from soma) in axons on DIV2,
the accumulation of red signal in nucleus wasmeasured 2min later. To control for nonspecific photoconversion during imaging of Dendra2 or Dendra2-SMAD1 in
neuronal nuclei, nonphotoconverted neurons in the samemicroscopic field as the photoconverted neurons were used as controls. Photoconversion of Dendra2-
SMAD1 in axons resulted in a significant increase in photoconverted Dendra2-SMAD1 in the nucleus, compared with Dendra2.
For quantifications, bars indicate mean ± SEM, n = 3 replicates. More than 20 axons (A) and neurons (D) for each treatment were analyzed. ns, not significant,
*p < 0.05, **p < 0.01 (post hoc Tukey’s test after one-way ANOVA compared with the vehicle treatment group in A and B, and 0 min time point group in D).
See also Figure S5.
Neuron
Local Translation Regulates Trigeminal Patterningover in axons. To determine themechanism that leads to the loss
of SMAD1/5/8 after protein synthesis inhibition, we examined
SMAD1/5/8 levels in severed trigeminal axons. Severed axons
can remain in culture for at least 2 hr before displaying signs of
degeneration (Figure S5A). As expected, axonal SMAD1/5/8
levels dropped significantly upon axonal application of anisomy-
cin (Figure 5A). However, the rapid decline in SMAD1/5/8 levels
was not due to proteasomal degradation, since the proteasome
inhibitor N-acetyl-L-leucinyl-L-leucinal-L-norleucinal (LLnL),
which prevents SMAD degradation (Gruendler et al., 2001), did
not block the decline in axonal SMAD1/5/8 levels (Figure 5A).
We next considered the possibility that the loss in SMAD1/5/8
levels reflects retrograde trafficking of SMAD1/5/8 from distal100 Neuron 74, 95–107, April 12, 2012 ª2012 Elsevier Inc.axons. Consistent with this model, treatment of axons with the
dynein inhibitor EHNA prevented the reduction of axonal
SMAD1/5/8 after protein synthesis inhibition (Figures 5A and
S4E). Taken together, these data suggest that SMAD1/5/8 is
transported retrogradely from distal axons in amotor-dependent
manner.
To track the fate of axonally synthesized SMAD1/5/8, we used
L-azidohomoalanine (AHA), a methionine analog that can be
biotinylated using ‘‘click chemistry’’ (Kiick et al., 2002). E13.5
trigeminal ganglia neurons were cultured in microfluidic cham-
bers, and AHA was added to the axonal compartment. AHA
was allowed to incorporate into locally synthesized proteins,
and the axonally synthesized, retrogradely trafficked proteins
Figure 6. Retrograde BMP4 Signaling Requires
Axonally Synthesized SMAD1/5/8
(A) Selective depletion of SMAD1/5/8 from distal axons.
Both siRNA cocktails (siRNA 2-1-1 and 3-3-3), containing
siRNAs specific to individual SMAD1, 5, and 8 mRNAs,
lead to a significant reduction (by 67%–75%) in axonal
SMAD1/5/8 (red) protein levels compared with a non-
targeting siRNA control. Tau1 staining (green) was used to
define the borders of axons and growth cones for fluo-
rescence measurements. Scale bar represents 10 mm.
(B and C) Retrograde BMP4 signaling is impaired following
axonal knockdown of SMAD1, 5, and 8. Knockdown of
axonal SMAD1, 5, and 8 inhibited BMP4-mediated retro-
grade induction of pSMAD1/5/8 by 68%–76% (B) and
Tbx3 by 51%–62% (C).
For quantification, all data are mean ± SEM, n = 3 repli-
cates. Between 100 and 200 cells (B and C) andmore than
15 axons (A) were analyzed for each condition. ns, not
significant, **p < 0.01, *p < 0.05 (compared with control
siRNA group, post hoc Tukey’s test after one-way
ANOVA). See also Figure S6.
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Local Translation Regulates Trigeminal Patterningwere collected by preparing lysates from the cell body compart-
ment. pSMAD1/5/8 was immunoprecipitated and the presence
of axonally derived AHA-labeled pSMAD1/5/8 was detected by
anti-biotin western blotting. Biotinylated pSMAD1/5/8 was
observed in cell bodies with axons treated with BMP4 after
immunoprecipitation and click reaction (Figure 5B). This effect
was blocked by including anisomycin in the axon, demonstrating
that the biotinylated pSMAD1/5/8 was synthesized in axons (Fig-
ure 5B). Together, these experiments show that endogenous,
axonally derived SMAD1/5/8 is translocated to the cell body in
its transcriptionally active phosphorylated form.
To further examine the retrograde trafficking of axonal SMAD,
we imaged Dendra2-SMAD1 in axons. Dendra2 or Dendra2-
SMAD1 was photoconverted to the red fluorescent form in the
axon, and the distribution of the red signal was monitored over
50 s (Figure 5C). Red fluorescent Dendra2-SMAD1 preferentially
localized to the proximal side of the photoconverted segment,
consistent with the transport of SMAD protein in a retrograde
manner (Figures S5B andS5C). The retrogradely transportedDen-
dra2-SMAD1 accumulates in the nucleus aswe detected a signifi-
cant increase of red signal in the nucleus after photoconverting
Dendra2-SMAD1 in axon (Figure 5D). Collectively, these experi-
ments suggest that axonal SMAD can be retrogradely trafficked
back from the axon to the soma and accumulates in the nucleus.
BMP4 receptors typically bind to SMADs through adaptor
proteins (Moustakas and Heldin, 2009; Shi et al., 2007). To deter-
mine if axonal SMAD associates with BMP4 receptors, we exam-
ined the localization of axonal SMAD1/5/8 with respect to
signaling endosomes labeled with biotinylated BMP4. Following
application of biotinylated BMP4 to the axonal compartment,
biotinylated BMP4 exhibited significant colocalization with both
axonal pSMAD1/5/8 and SMAD1/5/8 (Figure S5D), compared
with biotinylated BSA. These data suggest that SMAD1/5/8
associates with BMP4 receptor complexes in axons.Retrograde Gene Induction Requires Axonally
Synthesized SMAD1/5/8
We next asked whether axonal SMAD is required for retrograde
BMP4 signaling. To address this, we generated neurons with
reduced SMAD1/5/8 transcripts in axons using compartmental-
ized siRNA transfection (Hengst et al., 2006). We prepared two
siRNA cocktails, each containing three siRNAs, one for each of
the SMAD1, 5, and 8 isoforms. Transfection of either SMAD1/
5/8 knockdown cocktail, but not the nontargeting control siRNA,
into the axonal compartment resulted in significant reduction
in axonal SMAD levels, measured using isoform-specific anti-
bodies (Figures S6A–S6C) or using an antibody to SMAD1/5/8
(Figure 6A). Axonal transfection of either siRNA cocktail did not
significantly affect transcript levels in cell bodies, as measured
by SMAD1, 5, and 8 FISH analysis (Figures S6D–S6F). These
results confirm that compartmentalized siRNA transfection only
affected SMAD1, 5, and 8 transcript levels in axons.
To determine if axonal SMAD mediates retrograde BMP4
signaling, we applied BMP4 to axons after compartmentalized
knockdown of SMAD1/5/8. In these axonal SMAD1/5/8-
deficient neurons, retrograde BMP4 signaling was significantly
impaired, as measured by reduced induction of nuclear
pSMAD1/5/8 and Tbx3 by axonal BMP4 treatment (Figures 6B,
6C, and S6G). No effect on retrograde trafficking of BMP4
endosomes was observed in axons transfected with the SMAD
siRNA cocktail (Figure S6H). These data indicate that axonal
SMAD is required for retrograde BMP4 signaling.
BDNF Induces Intra-axonal SMAD1/5/8 Synthesis
Our finding that axonal SMAD1/5/8 mediates retrograde BMP4
signaling suggests that factors which regulate axonal synthesis
of SMAD1, 5, and 8 would be required for proper patterning of
the trigeminal ganglia. To screen for factors that induce
SMAD1/5/8 synthesis, we examined SMAD1/5/8 levels inNeuron 74, 95–107, April 12, 2012 ª2012 Elsevier Inc. 101
Figure 7. BDNF Acts Locally to Regulate SMAD1/
5/8 Translation and Retrograde BMP4 Signaling
(A) BDNF induces intra-axonal synthesis of SMAD1/5/8.
E13.5 trigeminal explants were grown in microfluidic
chambers for 2 days, and then neurotrophin-free media
was applied to the axonal compartment for 24 hr.
Axons were then severed to ensure that any increase in
SMAD1/5/8 levels do not derive from transport from the
soma. Axons were treated with BMP4 (20 ng/ml), BDNF
(25 ng/ml), anisomycin (Aniso, 200 mM), NT-3 (50 ng/ml), or
NGF (50 ng/ml) for 30 min. In untreated axons, SMAD1/5/8
(red) levels are nearly undetectable. However, SMAD1/5/8
levels increase significantly upon application of BDNF.
This increase is blocked by anisomycin, indicating that the
increase in SMAD1/5/8 levels derives from an increase in
local translation. Substantially less or no induction was
seen following treatment with other neurotrophins or
BMP4. Tau1 staining (green) was used to define the
borders of axons and growth cones for fluorescence
measurements. Scale bar represents 10 mm.
(B) Quantification of results in (A). BDNF induced a 1.7-fold
increase in axonal SMAD1/5/8 levels, which was blocked
with anisomycin. NT-3 induced a substantially smaller,
although statistically significant 0.7-fold increase in axonal
SMAD1/5/8 levels.
(C) Retrograde BMP4 signaling requires both BDNF
and BMP4. Dissociated E13.5 trigeminal neurons were
cultured in microfluidic chambers for 2 days, and then the
media was switched to neurotrophin-free media for 4 hr.
Axonswere treatedwithNGF/NT-3, BDNF, orBMP4, alone
and in combination for 1 hr, and nuclear pSMAD1/5/8
was measured by immunofluorescence. Retrograde
induction of pSMAD1/5/8 was not elicited by axonal
application of NGF/NT-3, BDNF, or BMP4 alone but was
only observed when both neurotrophins and BMP4 were
applied to axons.Nuclear pSMAD1/5/8 levels increasedby
96.1% following axonal application of both BDNF
and BMP4 and by 36.6% after axonal application of both
NGF/NT-3 and BMP4.
(D) BDNF functions locally to regulate retrograde BMP4
signaling. Retrograde BMP4 signaling was blocked
following axonal application of K252a (2 mM), but not
application of K252a to the cell body. BDNF was present
in the culturing media.
For quantification, all data are mean ± SEM, n = 3 replicates. Between 100 and 200 cells (C and D) and more than 15 axons (B) were analyzed for each condition.
ns, not significant, *p < 0.05, **p < 0.01, compared with vehicle (B and C) or axonal BMP4 treatment (D) group as indicated, post hoc Tukey’s test after one-way
ANOVA. See also Figure S7.
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Standard trigeminal ganglia neuron culturing media contains
NT-3 and NGF. However, in this experiment, the axonal
compartment of E13.5 trigeminal neurons was switched to neu-
rotrophin- and BMP4-free media for 24 hr prior to severing.
Notably, levels of axonal SMAD1/5/8 were essentially abolished
24 hr after switching to this media. We first asked if BMP4
induces SMAD1/5/8 in axons. However, treatment of axons
with BMP4 did not increase SMAD1/5/8 levels significantly
higher than background (Figures 7A and 7B).
We next considered the possibility that neurotrophins might
regulate axonal SMAD levels, since these molecules have been
shown to induce intra-axonal protein synthesis (Cox et al.,
2008; Hengst et al., 2009; Yao et al., 2006; Zhang and Poo,
2002). Application of NGF did not induce a significant increase
in axonal SMAD levels, while application of NT-3 caused a small102 Neuron 74, 95–107, April 12, 2012 ª2012 Elsevier Inc.but significant increase in axonal SMAD levels (Figures 7A and
7B). However, despite the effect of NT-3, it is unlikely to be the
major physiological regulator of axonal SMAD1/5/8 synthesis
since NT-3 is expressed in the ophthalmic, maxillary, and
mandibular regions of the face (Aruma¨e et al., 1993; O’Connor
and Tessier-Lavigne, 1999), while axonal SMAD1/5/8 is detected
only in axons innervating the ophthalmic and maxillary regions
(see Figures 3A and S3A).
Therefore, we next considered BDNF, which exhibits a highly
specific ophthalmic and maxillary epidermal expression pattern,
with no detectable levels in the mandibular region of the face
(Aruma¨e et al., 1993; O’Connor and Tessier-Lavigne, 1999).
Application of BDNF to severed axons caused a 1.7-fold
increase in axonal SMAD levels in 30 min (Figures 7A and 7B).
This increase was blocked by coapplication of anisomycin, indi-
cating that axonal SMAD induction by BDNF is local synthesis
Neuron
Local Translation Regulates Trigeminal Patterningdependent (Figures 7A and 7B). As a control, Tau1 and TrkB
receptor levels were not affected by these treatments (Figures
S7A–S7C). These data indicate that neurotrophins, especially
BDNF, induce SMAD expression in axons via local protein
synthesis.
Retrograde Gene Induction Requires Coordinated
Actions of BDNF and BMP4
Our data indicate that retrograde induction of nuclear pSMAD1/
5/8 and Tbx3 requires target-derived BDNF-dependent intra-
axonal synthesis of SMADs. Previous studies suggested that
BMP4 was the primary regulator of pSMAD1/5/8 induction
(Hodge et al., 2007). However, these experiments utilized bath
application of BMP4, which results in activation of BMP4 recep-
tors primarily on cell bodies. Because cell bodies express
SMAD1/5/8 even in the absence of neurotrophins (Figure 3B),
these studies do not address signaling in axons, which express
SMAD1/5/8 only in the presence of neurotrophins. To test the
idea that both BMP4 and neurotrophins are required for retro-
grade signaling, we cultured E13.5 trigeminal ganglia neurons
in microfluidic chambers, and after 2 days switched the media
to neurotrophin-free media for 4 hr. Under thesemodified culture
conditions, axonal application of BMP4 for 1 hr failed to elicit
retrograde induction of nuclear pSMAD1/5/8 (Figure 7C). Simi-
larly, axonal application of BDNF for 1 hr was unable to induce
nuclear pSMAD1/5/8. However, coapplication of BDNF and
BMP4 resulted in retrograde induction of nuclear pSMAD1/5/8
(Figure 7C). In each of these treatments, total cell body
SMAD1/5/8 levels were not significantly affected (Figure S7D).
These data indicate that BMP4 is not sufficient for retrograde
signaling, but requires collaboration with neurotrophins.
To determine whether the induction of pSMAD1/5/8 and Tbx3
by axonally applied BDNF also requires a retrogradely trafficked
TrkB signaling endosome, we used the Trk inhibitor K252a
(Tapley et al., 1992). Application of K252a to axons of E13.5
trigeminal ganglia neurons in microfluidic chambers blocked
the ability of axonally applied BDNF and BMP4 to induce Tbx3,
without affecting retrograde transport of BMP4 signaling endo-
somes (Figures 7D and S7E). These data indicate that the effects
of BDNF in mediating retrograde BMP4 signaling reflect local,
intra-axonal actions of BDNF and do not require the activity of
Trk receptors in the cell body. Together, these data indicate
that BDNF and BMP4 receptors have roles in distinct compart-
ments within the neuron to mediate retrograde signaling. BDNF
is required within the axon, where it acts to regulate intra-axonal
SMAD1/5/8 synthesis, while axonal application of BMP4 induces
the appearance of BMP4 receptor activity in the cell body.
Target-Derived BDNF Regulates Axonal SMAD1/5/8
Expression and the Acquisition of Positional Identity
Markers during Trigeminal Ganglia Development
We next wanted to assess whether target-derived BDNF has
a physiological role in regulating the levels of SMAD1/5/8 in
axons in developing embryos. During early embryonic develop-
ment, BDNF expression is principally localized to the maxillary
and ophthalmic mesenchyme, with highest expression toward
the epithelium, but is absent from the mandibular mesenchyme
(Aruma¨e et al., 1993; O’Connor and Tessier-Lavigne, 1999).The absence of BDNF in the mandibular mesenchyme matches
with the absence of SMAD1/5/8 from the mandibular branch in
E12.5 mouse embryos (Figures 3A and S3A). This correspon-
dence suggests a causal role for BDNF in controlling axonal
SMAD1/5/8 levels in vivo.
To determine if BDNF physiologically regulates axonal SMAD
levels, we examined axonal SMAD levels in maxillary and
ophthalmic axons of the trigeminal ganglia in E12.5 BDNF/
mouse embryos. BDNF/ embryos exhibit normal trigeminal
ganglion development, as well as normal trigeminal axon growth
and pathfinding in early embryonic development (Ernfors et al.,
1994; O’Connor and Tessier-Lavigne, 1999). While SMAD1/5/8
was readily detectable in maxillary axons of BDNF+/ littermate
control embryos, axonal SMAD1/5/8 levels were markedly
reduced in BDNF/ embryos (Figures 8A and S8A–S8C).
Similarly, SMAD1/5/8 levels were markedly reduced in the
ophthalmic bundle in BDNF/ embryos compared to BDNF+/
littermate controls (Figure S8D). These data suggest that
target-derived BDNF physiologically regulates the expression
of SMAD1/5/8 in axons.
Our experiments using cultured neurons suggest that BDNF
promotes the ability of BMP4 to retrogradely induce the ex-
pression of Tbx3, a positional identity marker for maxillary/
ophthalmic trigeminal neurons. To further examine this idea,
we asked whether mandibular neurons can be induced to
express maxillary/ophthalmic positional identity markers.
Explants derived from either the maxillary/ophthalmic or the
mandibular portion of E13.5 rat trigeminal ganglia were cultured
in microfluidic chambers. Application of BDNF/BMP4 to the
axonal compartment led to Tbx3 expression in both maxillary/
ophthalmic and mandibular explants (Figure S8E). These results
suggest that the mandibular neurons have the capacity to
express maxillary/ophthalmic positional identity markers, but
most likely do not because they are not physiologically exposed
to BDNF and BMP4.
To address the physiological role of BDNF in regulating
the patterning of the trigeminal ganglia, we examined posi-
tional identity markers in BDNF/ embryos. In E12.5 control
(BDNF+/) embryos, pSMAD1/5/8 and Tbx3 are highly ex-
pressed in the nuclei of maxillary- and ophthalmic-innervating
neurons of the trigeminal ganglia (Figure 8B). However, in
BDNF/ embryos, nuclear pSMAD1/5/8 and Tbx3 staining in
the ophthalmic and maxillary regions of the trigeminal ganglia
is reduced to levels seen in the mandibular region of the trigem-
inal ganglia (Figures 8B–8D). The loss of nuclear pSMAD and
Tbx3 signals reflects reduced expression levels, not the loss of
neurons, since neuronal number, as measured by Isl1 staining,
is unaffected (Figure 8B). These data indicate that target-derived
BDNF is critical for the acquisition of positional identity markers
in the trigeminal ganglia.
We considered the possibility that the induction of the posi-
tional identity markers was delayed in BDNF/ embryos.
However, Tbx3 expression was also absent at E13.5 (Figures
8B). As an additional control, we examined whether BMP4
expression was affected in BDNF/ embryos. Immunostaining
of BMP4 in the face was essentially identical in BDNF+/ and
BDNF/ embryos (Figure S8F), indicating that impaired expres-
sion of positional identity markers in the trigeminal gangliaNeuron 74, 95–107, April 12, 2012 ª2012 Elsevier Inc. 103
Figure 8. Loss of Axonal SMAD1/5/8
Protein and Trigeminal Ganglia Positional
Identity Markers in BDNF–/– Embryos
(A) Loss of SMAD1/5/8 in maxillary (MX) axons in
BDNF/ embryos. BDNF is expressed in the
maxillary and ophthalmic target fields of the
trigeminal ganglia. SMAD1/5/8 (red) is readily
detectable in the maxillary axonal projections
(arrows) of the trigeminal ganglia in E12.5BDNF+/
mouse embryos. However, axonal SMAD1/5/8
staining is significantly reduced in BDNF/
embryos (arrowheads), indicating a role for BDNF
in regulating axonal SMAD1/5/8 levels. Axon
projections were visualized by Tau1 immunofluo-
rescence (green). The quantification shows that
SMAD1/5/8 labeling was decreased by 60.0% in
the axon projections of BDNF/ embryos
compared to BDNF+/ littermates.
(B) Loss of pSMAD1/5/8 and Tbx3 expression in
the trigeminal ganglia in BDNF/ embryos.
Expression of both markers is readily detected in
sections of the trigeminal ganglia from E12.5
BDNF+/ embryos. However, expression of both
markers is essentially abolished in BDNF/
embryos. Induction of Tbx3 mRNA was also as-
sessed at E13.5 by in situ hybridization. Tbx3
transcripts were readily detected in BDNF+/
embryos but not in BDNF/ embryos. Trigeminal
neuron cell bodies were visualized by Isl1 immu-
nofluorescence (green). Isl1 staining was used to
identify neuronal nuclei for quantification of
pSMAD1/5/8 and Tbx3 (C and D) and to confirm
normal trigeminal ganglia formation in BDNF/
embryos. A portion of the trigeminal ganglia is
shown at higher power to demonstrate changes in
staining intensity in the nucleus. The red dotted
lines indicate the boundary between the maxillary/
ophthalmic (MX/OP) and mandibular (MD) regions
of the trigeminal ganglia.
(C and D) Quantification of loss of pSMAD and
Tbx3 expression seen in (B). Nuclear pSMAD1/5/8
and Tbx3 signals were quantified in maxillary and
ophthalmic regions (MX/OP) and mandibular (MD)
regions of trigeminal ganglia. Isl1 labeling was
used as a mask to demarcate the borders of
neuronal nuclei for quantification. Nuclear pSMAD
(C) and Tbx3 (D) expression in MX/OP of BDNF/
embryos was reduced by 46.2% and Tbx3 by
62.4%, to the low baseline levels seen in the MD
region of the ganglia. The expression of these
markers in theMD portion of the trigeminal ganglia
was not affected in the BDNF/ embryos.
For quantifications (A, C, and D), all data are mean ± SEM, n = 3 replicates. Between 4 and 5 sections were analyzed for each genotype. ns, not significant,
*p < 0.05, **p < 0.01, unpaired, two-tailed t test. Scale bars represent 50 mm (A); 100 mm (B). See also Figure S8.
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embryos. Lastly, we addressed whether SMAD transcript
expression levels are affected in BDNF/ embryos. In situ
hybridization shows that SMAD1, 5, and 8 expression was
unaffected in BDNF/ embryos (Figure S8G), suggesting that
reduced pSMAD in neuronal nuclei and SMAD in axons is not
due to impaired SMAD transcription. Together, these data indi-
cate that BDNF is a target-derived factor that physiologically
regulates axonal SMAD1/5/8 levels and is required for patterning
the trigeminal ganglia.104 Neuron 74, 95–107, April 12, 2012 ª2012 Elsevier Inc.DISCUSSION
Although combinations of distinct inductive cues are critical for
the specification of early neuronal types from neuronal progeni-
tors, it has not previously been known if multiple inductive cues
also act on axons to specify neuronal identity. In this case, distal
axons will require mechanisms to generate retrograde signals
that reflect the simultaneous detection of multiple cues. We
find that retrograde patterning of the trigeminal ganglia requires
both BMP4 and BDNF and that both signals act on distal axons
Neuron
Local Translation Regulates Trigeminal Patterningto generate a retrograde signal. Our results identify local transla-
tion as a mechanism that allows the axon to elicit a retrograde
signal only upon detection of both target-derived factors. We
find that SMAD1, 5, and 8 transcripts are localized to trigeminal
ganglia axons and that these mRNAs are selectively translated
in response to BDNF. Axonal SMAD1/5/8 is then retrogradely
trafficked to the cell body, along with BMP4 signaling endo-
somes, to regulate target gene transcription in the maxillary
and ophthalmic neuron subsets of the trigeminal ganglia (Fig-
ure S8H). In this manner, intra-axonal translation provides a
mechanism by which spatially and temporally coincident
target-derived signals are processed to obtain specific
responses, by limiting retrograde BMP4 signaling to regions
that also contain BDNF.
Our results also identify a new mechanism by which the tran-
scription factor repertoire of neuronal subtypes is determined.
Transcription factors have a central role in defining the identity
of neuronal subtypes, with the expression of specific combina-
tions of transcription factors linked to aspects of neuronal path-
finding, connectivity, and function (Dasen and Jessell, 2009;
Narita and Rijli, 2009). In most cases, transcription factors
involved in patterning are induced by morphogenic cues. Here,
we show that the transcription factors that regulate neuronal
identity can be stored in a latent form as axonally localized tran-
scripts, which are locally translated in response to specific
target-derived signals. These axonal transcription factors are
retrogradely trafficked to induce the gene expression programs
regulating neuronal fate and identity. Our data raise the intriguing
possibility that the local translation and retrograde trafficking of
transcription factors may be a recurrent feature in neuronal
subtype specification and patterning.
We find that BDNF and BMP4 have distinct and sequential
roles in retrograde signaling. Following BDNF-induced SMAD1/
5/8 synthesis in axons, BMP4 signaling is required for the tran-
scriptional activity of axonally derived SMAD1/5/8 in the cell
body. The axonally derived SMAD1/5/8 pool may be a preferen-
tial target for BMP4 signaling endosomes because of themanner
in which BMP4 receptors phosphorylate their targets. BMP4
receptors preferentially phosphorylate SMADs that they are
directly coupled to via adaptor proteins such as endofin (Mous-
takas and Heldin, 2009; Shi et al., 2007). Indeed, we find that
SMAD1/5/8 is colocalized with BMP4 signaling endosomes in
axons, suggesting direct phosphorylation of axonally derived
SMAD1/5/8. Consistent with this idea, SMAD1/5/8 is present in
a phosphorylated form in axons (Hodge et al., 2007), confirming
direct regulation of SMADs in axons. Since phosphorylation is
a labile modification that is readily reversed by phosphatases,
mechanisms must exist to maintain SMAD1/5/8 in a phosphory-
lated form. The cotrafficking of SMAD1/5/8 with BMP4 signaling
endosomes may serve to maintain SMADs in a phosphorylated
form during retrograde trafficking, and once the axonally derived
SMAD1/5/8 enters the cell body.
The initial discovery of robust staining of pSMAD1/5/8 in axons
raised the question about the functional role for this localization
(Hodge et al., 2007). The relatively robust staining of SMAD1/5/8
that we found in axons suggests that the overall levels of
pSMAD1/5/8 derived from the axonal pool may be sufficient to
exert a transcriptional effect in trigeminal neurons. Additionally,other axon-specific modifications of SMAD1/5/8 may also influ-
ence the transcriptional activity of axonal SMAD1/5/8. Although
axonal SMADpromotes retrograde BMP4 signaling, it is possible
that pre-existing SMAD1/5/8 in the cell bodymay have access to
BMP4 signaling endosomes and contribute to overall retrograde
signaling. Additionally, other local translation events may also
promote retrograde signaling.
Although roles for intra-axonal translation have been well
studied in vitro, there is limited evidence for the physiological
significance of intra-axonal translation. Thus, data showing
that the localization of endogenous protein to axons is due to
local synthesis in vivo is lacking. The phenotype of the BDNF/
mouse provides evidence for the physiological significance for
the intra-axonal translation of SMAD1/5/8. BDNF/ mice
display a selective loss of SMAD1/5/8 from axons. This loss in
axonal SMAD1/5/8 is consistent with BDNF-dependent regula-
tion of SMAD1/5/8 translation in axons. The physiological impor-
tance of axonal SMAD is suggested by the markedly reduced
pSMAD1/5/8 and Tbx3 levels in the nucleus of ophthalmic
and maxillary-innervating neurons of the trigeminal ganglia of
BDNF/ mice, phenocopying the BMP4/ mouse (Hodge
et al., 2007).
The physiological importance of BDNF in regulating axonal
synthesis of SMAD1/5/8 is also supported by the absence of
SMAD1/5/8 in the mandibular axons in wild-type embryos.
Although all the trigeminal axonal populations contain SMAD1/
5/8 transcripts, the protein is selectively expressed in the
ophthalmic andmaxillary axons, which encounter BDNF in target
tissues. The absence of SMAD1/5/8 from mandibular axons is
likely due to the failure of these axons to encounter BDNF in
the mandibular target field.
Numerous other examples of neuronal subtype specification
and patterning have been linked to signaling by target-derived
factors (Chao et al., 2009; Hippenmeyer et al., 2004; Nishi,
2003). Coincident detection of multiple target-derived factors
may be an important mechanism to specifically delineate
specific neuronal pools. Indeed, another potential role for coinci-
dence detection is suggested by the finding that sensory neuron
specification is influenced by the combination of activin A, a
TGF-b family member, and NGF, a neurotrophin (Xu and Hall,
2007). Together, the findings in our study identify a coincidence
detector mechanism that allows axons to resolve complex
patterns of target-derived factors to control retrograde signaling
involved in neuronal specification.EXPERIMENTAL PROCEDURES
Neuronal Culture
Trigeminal ganglia harvested from E13.5 rat embryos were dissected and
cultured as reported previously (Ernfors et al., 1994). Expression constructs
were nucleofected (Amaxa) into E13.5 trigeminal neurons following the manu-
facturer’s instructions.Microfluidic Chamber Assays
Microfluidic chambers were prepared as described previously (Taylor et al.,
2005). The dissociated trigeminal neurons were plated in the cell body
compartment (see Figure S1A). After culturing for 2–3 DIV, axons typically
have grown across the microgrooves to the axonal compartment. Treatments
can be applied specifically to either axonal compartment or cell bodyNeuron 74, 95–107, April 12, 2012 ª2012 Elsevier Inc. 105
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Local Translation Regulates Trigeminal Patterningcompartment. Details of microfluidic chamber experiments can be found in the
Supplemental Information.
Immunostaining, Immunohistochemistry, and In Situ Hybridization
For all immunofluorescence experiments using cultured neurons in microflui-
dic chambers, trigeminal neuron cell bodies and axons were fixed with 4%
paraformaldehyde (PFA)/phosphate-buffered saline (PBS) (pH 7.4). For immu-
nohistochemistry, embryos were dissected, fixed and sectioned as described
previously (Ji et al., 2009). TUNEL assay was carried out as described
(ApoAlert DNA Fragmentation Assay Kit, Clontech). In situ hybridization on
mouse sections using DIG-labeled RNA probes was performed as described
(Schaeren-Wiemers and Gerfin-Moser, 1993). Fluorescence in situ hybridiza-
tion (FISH) in cultured trigeminal axons was carried out as reported (Vessey
et al., 2008). Fluorescent images were collected using a LSM 510 Zeiss
laser-scanning confocal microscope. Image collection, quantification and
statistical methods are described in the Supplemental Information. For coloc-
alization analysis, Manders colocalization coefficients were calculated using
Fiji/ImageJ (Coloc 2 plugin).
Axonal RNA RT-PCR
E13.5 rat trigeminal neurons were cultured in 10 microfluidic chambers (Taylor
et al., 2005; see Figure S3C) per replicate for 3 days. RNA was harvested by
applying 50 ml TRIZOL (Invitrogen) to either the axonal or cell body compart-
ment. Detailed protocols for axonal RNA RT-PCR can be found in the Supple-
mental Information.
Live Cell Imaging and Photoconversion of Trigeminal Neurons
Dissociated E13.5 trigeminal neurons were nucleofected with pDendra2-
SMAD1-30UTRSMAD1 and pDendra2. For details on FRAP and retrograde and
anterograde trafficking experiments, see the Supplemental Information.
Click Chemistry
E13.5 rat trigeminal neurons were cultured in microfluidic chambers for 2 days
before replacing the media with methionine-free media containing Click-iT
AHA (L-azidohomoalanine, 50 mM) (Invitrogen) in the axonal compartment.
pSMAD1/5/8 was immunoprecipitated and the click reaction was carried
out on the immunoprecipitate using Click-iT Protein Reaction Buffer Kit
(Invitrogen) and biotin-alkyne (40 mM) according to the manufacturer’s instruc-
tions. For details, see the Supplemental Information.
Knockdown using siRNA and shRNA
siRNA-mediated knockdown of SMAD1, 5, and 8 mRNAs in axons were
carried out using GeneSilencer siRNA Transfection Reagent (Genlantis) as
described previously (Hengst et al., 2006, 2009). shRNA against receptors
were designed using OligoEngine Workstation and constructs were made in
pSUPER.GFP vector (OligoEngine). pSUPER.GFP.shRNA constructs were
introduced into trigeminal neurons by nucleofection. Target sequences and
detailed experimental designs can be found in the Supplemental Information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes eight figures and Supplemental
Experimental Procedures can be found with this article online at
doi:10.1016/j.neuron.2012.02.022.
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